Results 1 to 10 of about 1,499,954 (350)

Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD

open access: yesGut, 2021
Objective Delayed second dose SARS-CoV-2 vaccination trades maximal effectiveness for a lower level of immunity across more of the population. We investigated whether patients with inflammatory bowel disease treated with infliximab have attenuated ...
Nicholas A. Kennedy   +2 more
exaly   +2 more sources

Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines

open access: yesmBio, 2019
Nonstructural protein 1 (NS1) of influenza virus is a key virulence element with multifunctional roles in virus replication and a potent antagonist of host immune response.
Pui Wang   +17 more
doaj   +2 more sources

SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters

open access: yesNature, 2022
The recent emergence of B.1.1.529, the Omicron variant1,2, has raised concerns of escape from protection by vaccines and therapeutic antibodies. A key test for potential countermeasures against B.1.1.529 is their activity in preclinical rodent models of ...
Peter J Halfmann   +2 more
exaly   +2 more sources

Natural Attenuated Vaccines for Pasteurella multocida [PDF]

open access: yesBiology
Pasteurella multocida is capable of infecting various animal species, causing hemorrhagic septicemia or infectious pneumonia, and it is widely prevalent and pathogenic worldwide.
Qingyuan Xu   +3 more
doaj   +2 more sources

Biomarkers of safety and immune protection for genetically modified live attenuated Leishmania vaccines against visceral leishmaniasis-Discovery and implications

open access: yesFrontiers in Immunology, 2014
Despite intense efforts there is no safe and efficacious vaccine against visceral leishmaniasis, which is fatal and endemic in many tropical countries. A major shortcoming in the vaccine development against blood borne parasitic agents such as Leishmania
Sreenivas eGannavaram   +5 more
doaj   +2 more sources

Research Progress in the Development of Vaccines Against Riemerella anatipestifer [PDF]

open access: yesMicroorganisms
Riemerella anatipestifer (R. anatipestifer, RA) is a globally distributed pathogen responsible for duck serositis, an acute multisystemic disease whose infection leads to substantial economic impacts in duck production.
Junxvan Lan   +9 more
doaj   +2 more sources

Quality control procedure for Coccidial vaccines versus different routes of immunization [PDF]

open access: yesVeterinary World, 2022
Background and Aim: Coccidiosis is an enteric infection caused by a protozoon (Eimeria tenella). Coccidiosis is known to have a negative impact on the economy. Coccidiosis is controlled using anticoccidial drugs, antibiotics, and vaccines.
Arwa Elnaggar, Hala Mahmoud, Sahar Saber
doaj   +1 more source

Evaluate Risk Analysis of Measurement Uncertainty (MU) of Different Methods Applied for Veterinary Vaccines Evaluation [PDF]

open access: yesJournal of Applied Veterinary Sciences, 2022
Veterinary Serum and Vaccine Research Institute (VSVRI ) objected to producing highly efficient vaccines from reference or local isolates according to the international specifications for protecting animals and poultry against different diseases and ...
Hala Elsawy   +5 more
doaj   +1 more source

Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3

open access: yesNature, 2023
Mouse experiments and deep sequencing confirmed that two additional live attenuated vaccine candidates against type 1 and 3 polioviruses remained attenuated and preserved all documented nOPV2 characteristics concerning genetic stability following ...
Ming-Te Yeh   +7 more
semanticscholar   +1 more source

Comparative Evaluation of Lumpy Skin Disease Virus-Based Live Attenuated Vaccines

open access: yesVaccines, 2021
Vaccines form the cornerstone of any control, eradication and preventative strategy and this is no different for lumpy skin disease. However, the usefulness of a vaccine is determined by a multiplicity of factors which include stability, efficiency ...
A. Haegeman   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy